Dysregulated TIE-2 expression is associated with blood-brain barrier leakiness and Alzheimer's disease-related neuropathology.
Saved in:
| Title: | Dysregulated TIE-2 expression is associated with blood-brain barrier leakiness and Alzheimer's disease-related neuropathology. |
|---|---|
| Authors: | Ince S; Cerebrovascular & Dementia Research Group, Learning and Research Building, Bristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK., Van Hulle C; Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin, Madison, Wisconsin, USA., Kollmorgen G; Roche Diagnostics GmbH, Penzberg, Germany., Quijano-Rubio C; Roche Diagnostics International Ltd, Rotkreuz, Switzerland., Gleason C; Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Institute, University of Wisconsin, Madison, Wisconsin, USA., Bendlin BB; Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Institute, University of Wisconsin, Madison, Wisconsin, USA., Okonkwo O; Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Institute, University of Wisconsin, Madison, Wisconsin, USA., Asthana S; Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Institute, University of Wisconsin, Madison, Wisconsin, USA., Blennow K; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Zetterberg H; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Centre for Brain Research, Indian Institute of Science, Bangalore, India., Johnson SC; Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Institute, University of Wisconsin, Madison, Wisconsin, USA., Love S; Cerebrovascular & Dementia Research Group, Learning and Research Building, Bristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK., Miners JS; Cerebrovascular & Dementia Research Group, Learning and Research Building, Bristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK. |
| Source: | Brain pathology (Zurich, Switzerland) [Brain Pathol] 2026 Jun 07, pp. e70109. Date of Electronic Publication: 2026 Jun 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: International Society of Neuropathology Country of Publication: Switzerland NLM ID: 9216781 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-3639 (Electronic) Linking ISSN: 10156305 NLM ISO Abbreviation: Brain Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42252207 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dysregulated TIE-2 expression is associated with blood-brain barrier leakiness and Alzheimer's disease-related neuropathology. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ince+S%22">Ince S</searchLink>; Cerebrovascular & Dementia Research Group, Learning and Research Building, Bristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Van+Hulle+C%22">Van Hulle C</searchLink>; Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Kollmorgen+G%22">Kollmorgen G</searchLink>; Roche Diagnostics GmbH, Penzberg, Germany.<br /><searchLink fieldCode="AU" term="%22Quijano-Rubio+C%22">Quijano-Rubio C</searchLink>; Roche Diagnostics International Ltd, Rotkreuz, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gleason+C%22">Gleason C</searchLink>; Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Institute, University of Wisconsin, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Bendlin+BB%22">Bendlin BB</searchLink>; Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Institute, University of Wisconsin, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Okonkwo+O%22">Okonkwo O</searchLink>; Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Institute, University of Wisconsin, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Asthana+S%22">Asthana S</searchLink>; Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Institute, University of Wisconsin, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Blennow+K%22">Blennow K</searchLink>; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.<br /><searchLink fieldCode="AU" term="%22Zetterberg+H%22">Zetterberg H</searchLink>; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Centre for Brain Research, Indian Institute of Science, Bangalore, India.<br /><searchLink fieldCode="AU" term="%22Johnson+SC%22">Johnson SC</searchLink>; Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin, Madison, Wisconsin, USA.; Wisconsin Alzheimer's Institute, University of Wisconsin, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Love+S%22">Love S</searchLink>; Cerebrovascular & Dementia Research Group, Learning and Research Building, Bristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Miners+JS%22">Miners JS</searchLink>; Cerebrovascular & Dementia Research Group, Learning and Research Building, Bristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229216781%22">Brain pathology (Zurich, Switzerland)</searchLink> [Brain Pathol] 2026 Jun 07, pp. e70109. <i>Date of Electronic Publication: </i>2026 Jun 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22International+Society+of+Neuropathology%22">International Society of Neuropathology </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9216781 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1750-3639 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210156305%22">10156305 </searchLink><i>NLM ISO Abbreviation: </i>Brain Pathol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42252207 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bpa.70109 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e70109 Titles: – TitleFull: Dysregulated TIE-2 expression is associated with blood-brain barrier leakiness and Alzheimer's disease-related neuropathology. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ince S – PersonEntity: Name: NameFull: Van Hulle C – PersonEntity: Name: NameFull: Kollmorgen G – PersonEntity: Name: NameFull: Quijano-Rubio C – PersonEntity: Name: NameFull: Gleason C – PersonEntity: Name: NameFull: Bendlin BB – PersonEntity: Name: NameFull: Okonkwo O – PersonEntity: Name: NameFull: Asthana S – PersonEntity: Name: NameFull: Blennow K – PersonEntity: Name: NameFull: Zetterberg H – PersonEntity: Name: NameFull: Johnson SC – PersonEntity: Name: NameFull: Love S – PersonEntity: Name: NameFull: Miners JS IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 06 Text: 2026 Jun 07 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1750-3639 Titles: – TitleFull: Brain pathology (Zurich, Switzerland) Type: main |
| ResultId | 1 |